These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18849640)

  • 1. Long-term survival and prognostic indicators in small (Pongprasobchai S; Pannala R; Smyrk TC; Bamlet W; Pitchumoni S; Ougolkov A; de Andrade M; Petersen GM; Chari ST
    Pancreatology; 2008; 8(6):587-92. PubMed ID: 18849640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.
    Wasif N; Bentrem DJ; Farrell JJ; Ko CY; Hines OJ; Reber HA; Tomlinson JS
    Cancer; 2010 Jul; 116(14):3369-77. PubMed ID: 20564064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    You DD; Lee HG; Heo JS; Choi SH; Choi DW
    J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.
    Kim R; Tsao R; Tan A; Byrne M; Almhanna K; Lazaryan A; Elson P; Pelley RJ
    J Gastrointest Surg; 2010 Jul; 14(7):1159-69. PubMed ID: 20446118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.
    Duffy A; Capanu M; Allen P; Kurtz R; Olson SH; Ludwig E; Klimstra DS; O'Reilly EM
    J Surg Oncol; 2009 Jul; 100(1):8-12. PubMed ID: 19384918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.
    Huang L; Jansen L; Balavarca Y; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Besselink MG; Schrotz-King P; Brenner H
    BMC Med; 2018 Aug; 16(1):125. PubMed ID: 30126408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base.
    Kooby DA; Gillespie TW; Liu Y; Byrd-Sellers J; Landry J; Bian J; Lipscomb J
    Ann Surg Oncol; 2013 Oct; 20(11):3634-42. PubMed ID: 23771249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
    Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
    Cancer; 2010 Jun; 116(12):2932-40. PubMed ID: 20336787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection.
    Chiang KC; Yeh CN; Lee WC; Jan YY; Hwang TL
    World J Gastroenterol; 2009 Sep; 15(34):4305-10. PubMed ID: 19750574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.
    Hart PA; Law RJ; Frank RD; Bamlet WR; Burch PA; Petersen GM; Rabe KG; Chari ST
    Am J Gastroenterol; 2014 Sep; 109(9):1484-92. PubMed ID: 25070053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
    Colbert LE; Fisher SB; Hardy CW; Hall WA; Saka B; Shelton JW; Petrova AV; Warren MD; Pantazides BG; Gandhi K; Kowalski J; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Curran WJ; Landry JC; Maithel SK; Yu DS
    Cancer; 2013 Sep; 119(17):3148-55. PubMed ID: 23720157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
    Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
    J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
    Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic adenocarcinoma in young adults in a moroccan population.
    Raissouni S; Rais G; Mrabti H; Raissouni F; Mouzount H; Aitelhaj M; El Khoyaali S; Mohtaram A; Errihani H
    J Gastrointest Cancer; 2012 Dec; 43(4):607-11. PubMed ID: 22760710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.
    Scarpa A; Mantovani W; Capelli P; Beghelli S; Boninsegna L; Bettini R; Panzuto F; Pederzoli P; delle Fave G; Falconi M
    Mod Pathol; 2010 Jun; 23(6):824-33. PubMed ID: 20305616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
    Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
    JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis of veteran patients with pancreatic cancer.
    Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
    J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
    Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
    J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
    Neoptolemos JP; Stocken DD; Dunn JA; Almond J; Beger HG; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Lacaine F; Buckels J; Deakin M; Adab FA; Sutton R; Imrie C; Ihse I; Tihanyi T; Olah A; Pedrazzoli S; Spooner D; Kerr DJ; Friess H; Büchler MW;
    Ann Surg; 2001 Dec; 234(6):758-68. PubMed ID: 11729382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.